期刊文献+

术中5835输血方案临床应用研究 被引量:4

Clinical study on the 5835 transfusion scheme during operation
下载PDF
导出
摘要 目的探讨手术中应用自拟'5835'输血方案降低异体输血量的可行性与临床意义.方法术前ASA Ⅰ~Ⅱ级,择期行消化系统癌根治手术患者120例,以术中输血方案不同分3组:A组传统输血方案组;B组卫生部输血指南方案组;C组自行设计'5835'输血方案组,每组均观察40例.应用金科威UT4000F多功能监测仪持续监测NIBP、SpO2、ECG等指标,记录术中出血量、输血量,并分别于术前24 h、术中输血前、术后24 h测定血红蛋白(HGB)和红细胞压积(HCT).结果 (1)三组术中出血量相近,差异无显著性(P>0.05);输血量分别为(197±57)ml、(91±35)ml和(99±42)ml,A组与B或C两组对比差异均非常显著(P<0.01);而B与C组间对比虽然C组数值大于B组,但差异无显著性(P>0.05).(2)Hb与HCT组内不同时段对比差异均有显著性(P<0.01或P<0.05);组间对比术前差异无显著性;输血前A组显著高于B、C组(P<0.05);C组高于B组,但差异无显著性(P>0.05).结论手术期间应用5835输血方案可最大限度地落实卫生部<临床输血技术规范>关于'手术创伤输血指南'确定的输血标准,具有简便实用、易操作、易推广应用的优点. Objective To investigate the feasibility and significance in decreasing the amount of transfusion by using the serf-designed 5835 transfusion scheme during operation. Methods 120 patients with digestive carcinoma(ASAⅠ~Ⅱ before operation) were divided into three groups according to double blind random rule,40 cases in each group. Group A: traditional transfusion scheme, group B: transfusion scheme issued by the Ministry of Health,group C : self-designed 5835 transfusion scheme. The HGB and HCT were detected 24 hours before operation, during operation and 24 hours after operation. During operation NIBP, SpO2 and ECG were observed by UT4000F-monitor, and the amount of bleeding and transfusion was also recorded. Results There was no significant difference in the amount of bleeding among three groups ( P〉0.05 ), however, there was a signiticant difference in the mean amount of transfusion between group A and group B, C, which was (196.7±56.9)ml in group A, (91.2±34.6)ml in group B and (98.8±41.7)ml in group C.Although the mean amount of transfusion in group C was higher than that in group B,there was no significant difference between two groups( P〉0.05).There were significant differences in HGB and HCT at different period in the same group ( P〈0.01 or P〈0.05),but there was no significant difference among groups ( P〉0.05). Conclusion The 5835 transfusion scheme is the most proper one to practice the technical specification of clinical transfusion issued by the ministry of health, and it is simple, practicable and easy to be mastered and spread.
出处 《河北医药》 CAS 2005年第8期575-576,共2页 Hebei Medical Journal
基金 河北省科技厅成果项目 编号:NO20041062
关键词 术中 输血方案 临床应用 输血指征 operation indication of transfusion clinical scheme clinical significance
  • 相关文献

参考文献7

二级参考文献12

  • 1Entholzner E,Mielke L,Plotz W,et al.Hypervolemic hemodilution as a mean of preventing homologous blood transfusion.A simple alternative to acute normovolemic hemodilution.Fortschr Med,1994,112:410-414.
  • 2Mielke LL,Entholzner EK,Kling M,et al.Preoperative acute hypervolemic hemodilution with hydroxyethyl starch:an alternative to acute normovolemic hemodilution?Anesth Analg,1997,85:1412.
  • 3Entholzner E,Mielke L,Plotz W,et al. Hypervolemic hemodilution as a mean of preventing homologous blood transfusion. A simple alternative to acute normovolemic hemodilution. Fortschr Med, 1994,112: 410-414.
  • 4Mielke LL, Entholzner EK, Kling M, et al. Preoperative acute hypervolemic hemodilution with hydroxyethyl starch: an alternative to acute nomovolemic hemocilution? Anesth Analg, 1997,85:1412.
  • 5Hebert PC,Wells G,Blajchman MA,et al.A multicenter,randomized,controlled clinical trial of transfusion requirements in critical care.N Engl J Med,1999,340:409-417.
  • 6Vincent JL,Baron JF,Reinhart K,et al.Anemia and blood transfusion in critically ill patients.JAMA,2002,288:1499-1507.
  • 7Standl T,Burmeister MA,Schroeder F,et al.Hydroxyethyl Starch(HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilution.Anesth Analg,2003,96:936-943.
  • 8Singbartl K,Innerhofer P,Radvan J,et al.Hemostasis and hemodilution:a quantitative mathematical guide for clinical practice.Anesth Analg,2003,96:929-935.
  • 9王祥瑞,陈涌鸣,李雯,陈杰,杭燕南,孙大金.急性高容血液稀释对老年心脏手术病人脑氧合功能的影响[J].临床麻醉学杂志,2002,18(6):289-292. 被引量:61
  • 10郭晓丽,葛衡江,刘怀琼.急性高容量血液稀释对血液流变特性影响的临床研究[J].临床麻醉学杂志,2002,18(8):401-403. 被引量:45

共引文献11

同被引文献31

  • 1史计月,耿岩,侯宝君,安静,平付敏.术后贫血对生活质量的影响[J].中国全科医学,2004,7(15):1063-1064. 被引量:2
  • 2史计月,李金柱,王文格,杨晓光,侯宝君,张洪林,彭瑞芹,张爱民.维拉帕米-普鲁卡因合剂防治危重手术后急性呼吸窘迫综合征的临床观察[J].中国危重病急救医学,2005,17(6):357-360. 被引量:15
  • 3史计月,张方林,谷俊霞,张洪林,安静.芬太尼静滴用于术后镇痛的可行性观察[J].山东医药,2005,45(24):15-16. 被引量:8
  • 4史计月..围术期体液管理[A]..高凤兰,史计月,等,主编..现代疾病诊疗新进展..广州:广东科技出版社,,2004..634-637..
  • 5周光裕,译,吴肇光,校.输血与外科出血性疾病[A].曾宪九译.[美]D.C.萨比斯顿,主编.克氏外科学(下).北京:人民卫生出版社,1983:152-165.
  • 6邓硕曾 刘进.建议中华医学会制定输血指南[J].临床麻醉学杂志,1999,15:154-154.
  • 7祝学光.输血[A].吴在德,主编.外科学.笫5版.北京:人民卫生出版社,2001:35—40.
  • 8Garcia-Fernandez N, Lavilla F J, Rocha E. Haemostatic changes in systemic inflammatory response syndrome during continuous renal replacement therapy[J]. J Nephrol, 2000,13(4) :282-286.
  • 9Rachel C.M. Brierley,Katie Pike,Alice Miles,Sarah Wordsworth,Elizabeth A. Stokes,Andrew D. Mumford,Alan Cohen,Gianni D. Angelini,Gavin J. Murphy,Chris A. Rogers,Barnaby C. Reeves.??A multi-centre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and healthcare resource use following cardiac surgery: Study protocol(J)Transfusion and Apheresis Science . 2014
  • 10K. Nielsen,B. Dahl,P. I. Johansson,S. W. Henneberg,L. S. Rasmussen.??Intraoperative transfusion threshold and tissue oxygenation: a randomised trial(J)Transfusion Med . 2012 (6)

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部